AJOONI — Ajooni Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual balance sheet for Ajooni Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	7.31	1.24	2.44	0.574	4.93
Net Total Accounts Receivable
Net Total Receivables	60.3	139	157	160	246
Total Inventory
Total Other Current Assets
Total Current Assets	118	175	214	219	347
Net Property, Plant And Equipment	10.2	20.7	51.6	62.1	65.5
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	182	231	280	290	587
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.3	58.5	105	101	152
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	60.9	71.8	124	126	171
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	122	159	157	164	417
Total Liabilities & Shareholders' Equity	182	231	280	290	587
Total Common Shares Outstanding